The 2400% Solution
If you have not been following the International Custom Products, Inc. v. United States saga, you are missing out on quite the show.
Trending on the Topix Network
Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Vacated by Federal Circuit
MINNEAPOLIS, April 15, 2014 -- Vascular Solutions, Inc. announced that a three judge panel of the U.S. Court of Appeals for the Federal Circuit today vacated the preliminary injunction that was previously issued by the District Court for the District of Minnesota effective January 13, 2014 against Boston Scientific's Guidezilla guide extension ... (more)
Mon Apr 14, 2014
Judge Halts Use of Life Saving Heart Valve
A Medtronic implantable heart valve may be "safer" and present a "lower risk of death," but Medtronic is willfully infringing a competitor's version and therefore is being ordered off the market by a Delaware federal judge.
Sun Apr 13, 2014
Ruling keeps Chrysler case in the courts
About 150 dealerships that lost Chrysler franchises during the company's 2009 bankruptcy won a round in federal court last week when a three-judge panel agreed to let the dealers argue why the government should compensate them for ordering Chrysler to thin its ranks of dealers.
Thu Apr 10, 2014
Navigate: HUD Secretary Continues to Defy US Court of Appeals
Secretary Donovan told members of the House Appropriations Subcommittee on Transportation, Housing and Urban Development that HUD does not have to follow the same competitive contracting rules as other federal agencies.
Varian wins partial victory in radiation device patent case
Medical device company Varian Medical Systems Inc won a partial victory in a patent fight with the University of Pittsburgh on Thursday, when an appeals court disagreed with a lower court's multimillion-dollar damages award.
Wed Apr 09, 2014
Prosecution History of Original Examination as Intrinsic Evidence in...
In a case arising from an inter partes reexamination while pending district court litigation was stayed for more than eight years, the U.S. Court of Appeals for the Federal Circuit affirmed-in-part, vacated-in-part and remanded a decision of the U.S. Patent and Trademark Office's Patent Trial and Appeal Board that had reversed the examiner's ... (more)
Evidence in Support of Petition for Venue Transfer Must Be...
In two decisions from identical panels, the U.S. Court of Appeals for the Federal Circuit denied mandamus petitions seeking to direct two district courts to vacate their denials of petitioners' motions to transfer their respective cases.
Tue Apr 08, 2014
Press release distribution, EDGAR filing, XBRL, regulatory filings
SHAREHOLDER ALERT: Maryland-Based Law Firm Brower Piven Announces the Investigation of OBA Financial Services, Inc. over the Proposed Sale of the Company to F.N.B. Corporation )--The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current s...
Customer Interaction Solutions
Fish & Richardson Obtains Federal Circuit Affirmance of Patent...
The Federal Circuit's April 7, 2014 ruling came after nearly eight years of fierce litigation that included two district court cases, two Federal Circuit appeals, and ISE's request for over $400 million in damages plus trebling.
The Campbell Reporter
Apple seeks revival of standards suit against Google's Motorola
Apple asked a U.S. appeals court to revive its lawsuit claiming Google's Motorola Mobility unit demanded unreasonably high royalties for standard mobile-phone technology.
The Federal Circuit Considers Petitions For Rehearing Suprema - ...
The International Trade Commission and Cross Match Technologies Inc. requested rehearing of the December panel decision of the U.S. Court of Appeals for the Federal Circuit in Suprema Inc. and Mentalix Inc. v.
Amazon wins patent fight with Rovi in appeals court
Rovi, which sells television guide programs to cable providers, lost a patent fight with Amazon.com on Tuesday when an appeals court upheld a decision by a Delaware district court.
Mon Apr 07, 2014
Data Transaction Claim Not Patent Eligible - Cyberfone Systems, LLC v. CNN Interactive, Inc., et al.
The U.S. Court of Appeals for the Federal Circuit, in a ruling designated as non-precedential, affirmed the district court finding that a claimed method involved an "abstract idea" and was therefore not patent eligible.
Teva asks U.S. justices to stay lower court ruling in Copaxone case
Teva Pharmaceutical Industries Inc on Monday asked the U.S. Supreme Court to prevent an appeals court ruling from going into effect while the justices consider the company's appeal in a patent fight over top-selling multiple sclerosis drug Copaxone.
Fri Apr 04, 2014
Secret Practice of a Russian Invention on U.S. Soil Invalidates a...
Affirming the federal district court, the U. S. Court of Appeals for the Federal Circuit concluded that a claim was invalid under A 102 , i.e ., the invention was made in this country by another who had not abandoned, suppressed or concealed it, finding that the secret practice of the invention in the United States was prior art to the claimed ... (more)
A "Program" Is Just a Set of Instructions - Ancora Technologies, Inc. v. Apple, Inc.
In a case essentially decided on a single disputed claim construction, the U.S. Court of Appeals for the Federal Circuit rejected a narrow construction of the claim term "program" and construed the term, consistent with its ordinary meaning, to include any type of computer program.
Thu Apr 03, 2014
United States PTO Rejects Teva's '808 Patent Reissue Application on Copaxone for the Second Time
Mylan Inc. today announced that the United States Patent and Trademark Office issued a final office action rejecting Teva's application seeking a reissue of U.S. Patent No.
Federal Circuit Upholds Constitutionality Of Legislation Overturning...
This blog has been analyzing for more than four years legal disputes over whether the U.S. Department of Commerce may apply countervailing duties to imports from non-market economies , particularly China.
Looking Upstream: Weighing Proposed Changes To Customer Stays In Patent Litigation*
At a time when congressional partisanship is the norm, curbing lawsuits filed by nonpracticing entities may be one of the few issues uniting Washington.